UVB Irradiation, Mismatch Repair and Cutaneous Melanoma

  • S. Dooley
Conference paper


Msh2 is one of the genes involved in DNA-mismatch repair. Mutations in the coding region of the human gene (hmsh2) have been shown to be directly involved in microsatellite instability in hereditary nonpolyposis colorectal tumors. Examination of the promoter region of hmsh2 revealed a site with homology to the P53 consensus binding sequence. Using gel mobility shift experiments we were able to show that purified p53 has at least in vitro the potential to specifically bind the hmsh2-p53 motif. The binding activity was even stronger than the binding activity measured with the p53-consensus site. These data identify the hmsh2 gene as a possible novel p53-regulated target gene and indicate a direct involvement of p53 in repair mechanisms via DNA binding of a mismatch repair gene. Following UVB irradiation of human keratinocytes in cell culture we were able to transiently induce P53 expression with a subsequent increase in msh2-promoter binding activity, indicating a role of mismatch repair control after UVB damage. We are currently under way to examine in this context the involvement of microsatellite instability and the correlation of msh2 and p53 mutations in the pathogenesis of cutaneous melanoma using sections from paraffin-embedded tumor-tissue.


Mismatch Repair Cutaneous Melanoma Mismatch Repair Gene Satellite Instability Hmsh2 Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford, Lindblom A et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer. Nature 368: 258–261PubMedCrossRefGoogle Scholar
  2. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRefGoogle Scholar
  3. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475–1489PubMedCrossRefGoogle Scholar
  4. Drummond JT, Li GM, Longley MJ, Modrich P (1995) Isolation of an hMSH2-p 160 heterodimer that restores DNA mismatch repair to tumor cells [see comments]. Science 268: 1909–1912PubMedCrossRefGoogle Scholar
  5. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825PubMedCrossRefGoogle Scholar
  6. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolypo- sis colon cancer [published erratum appears in Cell 1994 Apr 8;77(1):167]. Cell 75: 1027–1038PubMedCrossRefGoogle Scholar
  7. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993): The p21 Cdk-interacting protein Cipl is a potent inhibitor of G 1 cyclin-dependent kinases. Cell 75: 805–816PubMedCrossRefGoogle Scholar
  8. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304–6311PubMedGoogle Scholar
  9. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJJ (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587–597PubMedCrossRefGoogle Scholar
  10. Kimmerly WJ, Kyle AL, Lustre VM, Martin CH, Palazzolo MJ (1994) Direct sequencing of terminal regions of genomic PI clones. A general strategy for the design of sequence-tagged site markers. Genet Anal Tech Appl 11:117–128PubMedGoogle Scholar
  11. Kinzler KW, Vogelstein B (1996) Life (and death) in a malignant tumor. Nature 379:19–20PubMedCrossRefGoogle Scholar
  12. Kolodner RD, Hall NR, Lipford J, Kane MF, Rao MRS, Morrison P, Finan PJ, Burn J, Chapman P, Earabino C, Merchant E, Bishop DT (1994) Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 24: 516–526PubMedCrossRefGoogle Scholar
  13. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491–7495PubMedCrossRefGoogle Scholar
  14. Loeb LA (1994): Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059–5063PubMedGoogle Scholar
  15. Lu X, Lane DP (1993) Differential induction of transcriptionally active p53, following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765–778PubMedCrossRefGoogle Scholar
  16. Morris GF, Bischoff JR, Mathews MB (1996) Transcriptional activation of the human prolifera ting-cell nuclear antigen promoter by p53. Proc Natl Acad Sci 93: 895–899PubMedCrossRefGoogle Scholar
  17. Oberosler P, Hloch P, Ramsperger U, Stahl H (1993) p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J 12: 2389–2396PubMedGoogle Scholar
  18. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD et al. (1994) Mutation of a mutL homolog in hereditary colon cancer [see comments]. Science 263:1625–1629PubMedCrossRefGoogle Scholar
  19. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, de-la-Chapelle A, Kinzler KW, Vogelstein B, Modrich P (1993) Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75:1227–1236PubMedCrossRefGoogle Scholar
  20. Service RF (1994) Stalking the start of colon cancer. Science 263: 1559–1560PubMedCrossRefGoogle Scholar
  21. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O’Connor PM, Fornace AJJ (1994): Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen [see comments]. Science 266:1376–1380PubMedCrossRefGoogle Scholar
  22. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG et al. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 10: 188–195PubMedCrossRefGoogle Scholar
  23. Wijnen J, Vasen H, Khan PM, Menko FH, van-der-Klift H, van-Leeuwen C, van-den-Broek M, van-Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer A et al. (1995): Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56:1060–1066PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • S. Dooley

There are no affiliations available

Personalised recommendations